Education
About Us
Working with TipRanks
Follow Us
ScandiDos AB (SE:SDOS)
:SDOS
SDOS Stock Chart & Stats
kr1.15
kr0.01(0.67%)
At close: 4:00 PM EST
kr1.15
kr0.01(0.67%)
Day’s Range― - ―
52-Week Rangekr0.90 - kr1.69
Previous CloseN/A
Volume16.76K
Average Volume (3M)69.69K
Market Cap
kr55.87M
Enterprise Valuekr50.18M
Total Cash (Recent Filing)kr5.70M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)51.8
Beta0.34
Next Earnings
Mar 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding57,011,086
10 Day Avg. Volume66,689
30 Day Avg. Volume69,692
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.28
Price to Sales (P/S)0.95
P/FCF Ratio-21.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Conservative Balance SheetNear-zero debt materially lowers solvency risk and gives management structural flexibility to fund operations or R&D without immediate refinancing pressure. Over a 2–6 month horizon this reduces bankruptcy risk and allows the company to endure cash burn while pursuing installed-base and software monetization strategies.
Healthy Product-level Gross MarginsA ~55% gross margin indicates the product and software mix retains strong pricing power and unit economics. If revenue stabilizes, these margins provide scope for operating leverage and sustainable profit conversion once fixed costs are controlled, underpinning long-term profitability potential.
Niche Radiotherapy QA Product And Recurring RevenuesThe company serves a specialized radiotherapy QA niche with hardware, software and aftersales services. Long equipment lifecycles, high switching costs and recurring service contracts create durable revenue streams and customer lock-in, supporting predictable installed-base cash flows over multiple quarters.
Bears Say
Negative And Deteriorating Free Cash FlowConsistent negative operating and free cash flow limits internal funding for product development, market expansion, or working capital. Structural cash burn forces reliance on external financing or equity issuance, which can dilute shareholders and constrain investment opportunities over the medium term if cash generation doesn't improve.
Persistent Operating Losses And Volatile ProfitabilityRecurrent negative EBIT and net losses reflect underlying execution and cost-structure issues. Volatile multi-year profits reduce the firm's ability to create retained earnings and build reserves, increasing the chance that operational fixes or restructuring will be required to achieve sustainable margins.
Flat To Declining Revenue TrendA stagnant or slightly declining top line constrains scale benefits and makes it harder to absorb fixed costs, slowing margin recovery. For a device-and-software business with long procurement cycles, persistent weak revenue growth risks prolonged pressure on margins and cash generation unless adoption accelerates.
SDOS FAQ
What was ScandiDos AB’s price range in the past 12 months?
ScandiDos AB lowest stock price was kr0.90 and its highest was kr1.69 in the past 12 months.
What is ScandiDos AB’s market cap?
ScandiDos AB’s market cap is kr55.87M.
When is ScandiDos AB’s upcoming earnings report date?
ScandiDos AB’s upcoming earnings report date is Mar 18, 2026 which is in 9 days.
How were ScandiDos AB’s earnings last quarter?
ScandiDos AB released its earnings results on Dec 16, 2025. The company reported kr0.005 earnings per share for the quarter, beating the consensus estimate of N/A by kr0.005.
Is ScandiDos AB overvalued?
According to Wall Street analysts ScandiDos AB’s price is currently Overvalued.
Does ScandiDos AB pay dividends?
ScandiDos AB does not currently pay dividends.
What is ScandiDos AB’s EPS estimate?
ScandiDos AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ScandiDos AB have?
ScandiDos AB has 57,011,086 shares outstanding.
What happened to ScandiDos AB’s price movement after its last earnings report?
ScandiDos AB reported an EPS of kr0.005 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.774%.
Which hedge fund is a major shareholder of ScandiDos AB?
Currently, no hedge funds are holding shares in SE:SDOS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ScandiDos AB
ScandiDos AB (publ) provides measurement systems and software designed for the QA and validation requirements of the new treatments implemented in clinics worldwide. The company offers Delta4 Family solution for pre treatment and at treatment dose verification covering various treatment technologies, such as VMAT, IMRT, SBRT, 4D-RT, and TomoTherapy; Delta4 Discover, a transmission detector that provides confidence and patient safety based on real time measurements; and Delta4 Phantom+, a system that offers accurate and verification of IMRT, VMAT, and TomoTherapy plans. It also provides HexaMotion, a motion management solution; Delta4DVH Anatomy, a software that verifies and analyzes the dose delivered in the patient anatomy; and Delta4 Machine QA, a software to perform QA with respect to rotation, start-up behavior, and dynamic beam modulation. The company was founded in 2005 and is headquartered in Uppsala, Sweden.
Technical Analysis
Clinical Laserthermia Systems AB Class B
―
SpectraCure AB
―
C-Rad AB Class B
―
Luxbright AB
―
Mentice AB
―